Octagon Capital Advisors’s Xilio Therapeutics XLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,785,000
| Closed | -$982K | – | 63 |
|
|
2023
Q4 | $982K | Sell |
1,785,000
-533,500
| -23% | -$293K | 0.16% | 30 |
|
|
2023
Q3 | $4.89M | Sell |
2,318,500
-106,500
| -4% | -$225K | 0.75% | 23 |
|
|
2023
Q2 | $6.35M | Hold |
2,425,000
| – | – | 0.88% | 22 |
|
|
2023
Q1 | $7.69M | Hold |
2,425,000
| – | – | 1.11% | 19 |
|
|
2022
Q4 | $6.52M | Hold |
2,425,000
| – | – | 1.02% | 22 |
|
|
2022
Q3 | $7.06M | Buy |
+2,425,000
| New | +$7.06M | 1.22% | 21 |
|